KYNAPID, created in 2007 (United States), from 67 sister brands and 17478 competing brands. The KYNAPID brand is owned by Astellas Pharma, a company listed in Francfort. The International Securities Identification Number (ISIN) of Astellas Pharma is JP3942400007. KYNAPID is part of the Drug Manufacturers activity sector.

KYNAPID is a brand of Astellas Pharma (YPH) Other brands